PeptideKey News

Iran War Disrupts 4,361 Trials, Breaks Peptide Routes

Iran war disrupts 4,361 clinical trials and 7,958 sites. Strait of Hormuz at 90% below normal threatens peptide API shipping from India and Gulf corridors.

This article is part of PeptideKey's evidence-based peptide research library covering 100+ compounds with lab-verified purity data.